Early protective effects of tiotropium bromide in patients with airways hyperresponsiveness

European Review for Medical and Pharmacological Sciences

Volumn 8, Issue 6, 2004, Pages 259-264

  Terzano, C ^b   Petroianni, A ^b   Ricci, A ^b   D'Antoni, L ^b   Allegra, L ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Airways hyperresponsiveness; Methacholine; Muscarinic receptors; Tiotropium

Indexed keywords

METHACHOLINE; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; PLACEBO; TIOTROPIUM BROMIDE;

ADULT; ANAMNESIS; ARTICLE; BRONCHODILATING ACTIVITY; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; MAXIMUM PERMISSIBLE DOSE; POWDER INHALER; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ADMINISTRATION, INHALATION; ADULT; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; BRONCHODILATOR AGENTS; CHOLINERGIC ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; METHACHOLINE CHLORIDE; SCOPOLAMINE DERIVATIVES;

EID: 13844300205     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gandevia B. Historical review of the use of parasympatholytic agents in the treatment of respiratory disorders. Postgrad Med J 1975; 51 (Suppl): 13-20.
2. Weber R. Role of anticholinergics in asthma. Ann Allergy 1990; 65: 348-350.
3. Beakes DE. The use of anticholinergics in asthma. J Asthma 1997; 34: 357-368.
4. Richardson JB. Nerve supply to the lungs. Am Rev Respir Dis 1979; 119: 785-802.
5. Barnes PJ. Muscarinic receptor subtypes in airways. Life Sci 1993; 52: 521-527.
6. Barnes PJ. Novel approaches and targets for treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: S72-79.
7. Lefkowitz RJ, Hoffman BB, Taylor P. Neurohumoral transmission: the autonomic and somatic motor nervous systems. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's the pharmacological basis of therapeutics, 8th ed. Elmsford, NY: Pergamon Press, Inc., 1990: 84-121.
8. Haddad EB, Mak JCW, Barnes PJ. Characterization of [3H]Ba 679 BR, a slowly dissociating muscarinic antagonist, in human lung: radioligand binding and autoradiographic mapping. Mol Pharmacol 1994; 45: 899-907.
9. Joos GF. Potential usefulness of inhibiting neural mechanisms in asthma. Monaldi Arch Chest Dis 2000; 55: 411-14.
10. O'Connor BJ, Towse LJ, Barnes PJ. Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma. Am J Respir Crit Care Med 1996; 154: 876-880.
11. Patel HJ, Barnes PJ, Takahashi T, et al. Evidence for prejunctional muscarinic autoreceptors in human and guinea pig trachea. Am J Respir Crit Care Med 1995; 152: 872-878.
12. Witek TJ, Disse B. Inhaled anticholinergic therapy: applied pharmacology and interesting developments. Curr Opin Invest Drugs 2001; 2: 53-58.
13. Disse B, Reichl R, Speck G, et al. BA 679 BR, a novel, long-acting anticholinergic bronchodilator. Life Sci 1993; 52: 537-544.
14. Disse B, Speck GA, Rominger KL, Witek TJ Jr, Hammer R. Tiotropium: mechanistical considerations and clinical profile in obstructive lung disease. Life Sci 1999; 64: 457-464.
15. American Thoracic Society. Guidelines for Methacholine and Exercise Challenge Testing-1999. Am J Respir Crit Care Med 2000; 161: 309-329.
16. Fryer AD, Jacoby DB. Effect of inflammatory cell mediators on M2 muscarinic receptors in the lungs. Life Sci 1993; 52: 529-536.
17. Minette PA, Lammers JW, Dixon CM, McCusker MT, Barnes PJ. A muscarinic agonist inhibits reflex bronchoconstriction in normal but not in asthmatic subjects. J Appl Physiol 1989; 67: 2461-2465.
18. Takahashi T, Belvisi M, Patel H, et al. Effect of Ba 679 BR, a novel long-acting anticholinergic agent, on cholinergic neurotransmission in guinea pig and human airways. Am J Respir Crit Care Med 1994; 150: 1640-1645.
19. Witek TJ, Souhrada JF, Serby CW, Disse B. Tiotropium (Ba 679): Pharmacology and early clinical observations; in Spector SS (ed): Anticholinergic Agents in the Upper and Lower Airways. New York, Dekker, 1999, pp 137-152.
20. van Noord JA, Bantje TA, Eland ME, et al, and the Dutch Tiotropium Study Group. A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease. Thorax 2000; 55: 289-294.
21. Littner MR, Ilowite JS, Tashkin DP, et al. Longacting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 1136-1142.
22. Celli B, ZuWallack R, Wang S, et al. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest 2003; 124: 1743-1748.
23. Rodrigo GJ, Rodrigo C. The Role of Anticholinergics in Acute Asthma Treatment. Chest 2002; 121: 1977-1987.
24. Maesen FPV, Smeets JJ, Costongs MAL, Wald FDM, Cornelissen PJG. Ba 679 BR, a new long-acting antimuscarinic bronchodilator: A pilot dose-escalation study in COPD. Eur Respir J 1993; 6: 1031-1036.
25. Maesen FPV, Smeets JJ, Sledsens TJH, et al. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8: 1506-1513.